All Blogs

Mar 18, 2022

Prostate cancer is the third most frequent cancer in the United States and the fourth most common worldwide. 1 in every 9 males in the United States will be diagnosed with Prostate Cancer at some time in their life. According to the American Cancer Society, Prostate Cancer is the second largest cause of cancer mort...

Mar 17, 2022

NeuroLogica Announces FDA 510(k) Clearance for Photon Counting Computed Tomography Using OmniTom Elite  On March 10, 2022, The state-of-the-art OmniTom Elite acquired 510(k) approval for the addition of Photon Counting Detector (PCD) technology, according to NeuroLogica Corp, a subsidiary of Samsung Electro...

Mar 16, 2022

Cannabidiol (CBD) is one of the 120 cannabinoids present naturally in cannabis plants. After tetrahydrocannabinol (THC), Cannabidiol is the second most prevalently available cannabinoid. Cannabidiol, an important component of medicinal marijuana, is either directly from the hemp plant or synthesized in a laboratory...

Mar 15, 2022

FDA Clears AstraZeneca and Merck’s Lynparza as an Adjuvant Breast Cancer Therapy The FDA approved the AstraZeneca and Merck drug for a specific group of patients with high-risk early breast cancer after chemotherapy treatment, either before or after surgery. Lynparza cements its position as the best-selling PARP...

Mar 14, 2022

Small Cell Lung Cancer (SCLC) is a particularly aggressive type of lung cancer. It is distinguished by the rapid and uncontrolled growth of certain cells in the lungs. A tumor forms eventually, and cancer can spread to other parts of the body. Small Cell Lung Cancer treatment usually involves chemotherapy, radiothe...

Mar 11, 2022

Peripheral nerve injuries were historically became known to mankind on the battlefield during Second World War. With technological advancements over the years, peripheral nerve injuries (PNI) have become more common which can be attributed to various reasons such as traumatic injuries, gunshot wounds, rising preval...

Mar 10, 2022

Bioventus Receives 501(k) Clearance for StimRouter Pain Management Device On March 1, 2022, the US Food and Drug Administration (FDA) gave Bioventus' StimRouter Neuromodulation System 510(k) approval. The next-generation pain treatment device is intended to treat chronic pain caused by peripheral nerves, ex...

Nov 04, 2025

Introduction With a growing number of people affected by osteoporosis and other bone-related conditions worldwide, there is an increasing need for accurate and accessible tools to check bone health. One of the most important devices used today is the bone densitometer, which measures bone mineral density (BMD), ...

Mar 08, 2022

Eli Lilly, Boehringer Ingelheim’s Jardiance Giving Competition to AstraZeneca’s Farxiga with EU Approval Jardiance, the diabetes blockbuster from Eli Lilly and Boehringer Ingelheim, recently received a Heart Failure label expansion in the United States. Now, the drug is expanding into Europe, with a nod that mig...

Mar 07, 2022

Cancer diagnostics is an umbrella term that encompasses all diagnostics modalities such as imaging, molecular diagnostics, and biopsy employed in drawing conclusions regarding cancer diagnosis and devising prognostic strategies.  Liquid Biopsy is comparatively a new technique in the cancer diagnosis and the...